Life sciences

  • This week’s health tech news from across the web

    To save you from trawling the web looking for health tech news, we have compiled bitesized versions of some of the top stories published on other sites this week. Scottish health tech company secures £1.7m for research Glasgow-based medical device specialist Nebuflow has secured an oversubscribed £1.7 million investment round, according to Digit News on May 10. [...]

  • Researchers conceive way to isolate super-swimming sperm

    Scientists have discovered a novel way of separating strong sperm cells from their impotent peers. By using an ingenious microchip method, researchers at Florida Atlantic University College of Engineering and Computer Science have developed a microfluidic chip for sperm sorting. The chip is fast, inexpensive, easy to operate and efficiently isolates healthy sperm directly from [...]

  • Geneos taps US$17m for advanced liver cancer trials

    Biotherapeutics specialist Geneos Therapeutics has clinched US$17m in second-round funding to help its development of tumour neoantigen targeted personalised immunotherapies for liver cancer patients. Led by Flerie Invest and backed by Santé Ventures, Korea Investment Partners – Global Bio Fund and INOVIO Pharmaceuticals, the investment will be used to bolster Geneos' GT-30 Phase Ib/IIa clinical [...]

  • Israeli tumour-beating pioneer lures life sciences VC to C-suite

    Israeli medical devices firm Alpha Tau Medical has lured Medstrada CEO Ruth Alon to its c-suite. The Nasdaq-listed developer of alpha-radiation cancer therapy believes the seasoned senior executive - with stints in venture capital and Silicon Valley consulting - will bring her extensive financial and strategic operations expertise to bear on the Tel Aviv-based firm. [...]

  • NeuroSense gets clearance for new MND treatment

    NeuroSense Therapeutics, a firm developing treatments for severe neurodegenerative diseases, has received clearance from the US FDA to initiate a pharmacokinetic study of its PrimeC innovation in healthy adult subjects. PrimeC is a novel extended-release oral formulation composed of a unique fixed-dose combination of two FDA-approved drugs: ciprofloxacin and celecoxib. PrimeC is designed to target [...]

  • Beneficial bugs evade immune system attack thanks to ingenious ‘cloak’

    Therapeutic bacteria can now 'hide' from being hunted down by immune systems, thanks to pioneering work performed at Columbia University in the US. Researchers report that they have developed a 'cloaking' system that temporarily hides the beneficial bugs from immune systems, allowing them to more effectively deliver drugs to tumours and kill cancer cells in [...]

  • Earthworm gives glue clue to nerve damage repair

    A self-healing earthworm could help people recover from nerve damage, according to work by University of Queensland researchers. Scientists at the Australian academy have identified a molecule, ADM-4, in nematode C.elegans that is essential for regulating the repair of injured nerves. According to Professor Massimo Hilliard, ADM-4 is an essential protein regulating the molecular glue, [...]

  • Cutting-edge innovation is not enough to save lives

    Staff are overstretched everywhere now, and that impacts collaboration and coordination of care

  • Miiskin opens skin tracking platform to dermatology research

    This will be available for researchers studying skin cancer, wound care, and conditions such as rosacea, acne, psoriasis and eczema.

  • CHAPPER healthcare to distribute pioneering asthma management tool

    "“We are excited to be working with an innovative company such as Pharmaxis to supply Osmohale® to customers in the UK and Ireland"